Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes

Behavioural Brain Research

Volumn 245, Issue , 2013, Pages 88-95

  Reinecke, Kirstin ^a   Herdegen, Thomas ^a   Eminel, Sevgi ^a   Aldenhoff, Josef B ^a   Schiffelholz, Thomas ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Anxiety; Behaviour; Exploration; JNK knockout; Learning; Memory

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 9; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME INACTIVATION; EXPLORATORY BEHAVIOR; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEMORY; MOUSE; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SPATIAL LEARNING; SPECIES DIFFERENCE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BODY WEIGHT; BRAIN; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MOTOR ACTIVITY; RECOGNITION (PSYCHOLOGY);

EID: 84875232957     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.02.013     Document Type: Article

References (83)

1. Herdegen T., Skene P., Bahr M. The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends in Neurosciences 1997, 20:227-231.
2. Haeusgen W., Herdegen T., Waetzig V. Specific regulation of JNK signalling by the novel rat MKK7gamma1 isoform. Cellular Signalling 2010, 22:1761-1772.
3. Bogoyevitch M.A., Ngoei K.R., Zhao T.T., Yeap Y.Y., Ng D.C. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochimica et Biophysica Acta 2010, 1804:463-475.
4. Silva R.M., Kuan C.Y., Rakic P., Burke R.E. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease. Movement Disorders 2005, 20:653-664.
5. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
6. Haeusgen W., Boehm R., Zhao Y., Herdegen T., Waetzig V. Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience 2009, 161:951-959.
7. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes and Development 1993, 7:2135-2148.
8. Morrison D.K., Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annual Review of Cell and Developmental Biology 2003, 19:91-118.
9. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 2001, 81:807-869.
10. Bjorkblom B., Vainio J.C., Hongisto V., Herdegen T., Courtney M.J., Coffey E.T. All JNKs can kill, but nuclear localization is critical for neuronal death. Journal of Biological Chemistry 2008, 283:19704-19713.
11. Tararuk T., Ostman N., Li W., Bjorkblom B., Padzik A., Zdrojewska J., et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. Journal of Cell Biology 2006, 173:265-277.
12. Waetzig V., Zhao Y., Herdegen T. The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Progress in Neurobiology 2006, 80:84-97.
13. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999, 22:667-676.
14. Waetzig V., Herdegen T. MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling. Molecular and Cellular Neurosciences 2005, 30:67-78.
15. Newbern J., Taylor A., Robinson M., Lively M.O., Milligan C.E. c-Jun N-terminal kinase signaling regulates events associated with both health and degeneration in motoneurons. Neuroscience 2007, 147:680-692.
16. Holmberg C., Katz S., Lerdrup M., Herdegen T., Jaattela M., Aronheim A., et al. A novel specific role for I kappa B kinase complex-associated protein in cytosolic stress signaling. Journal of Biological Chemistry 2002, 277:31918-31928.
17. Shoichet S.A., Duprez L., Hagens O., Waetzig V., Menzel C., Herdegen T., et al. Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy. Human Genetics 2006, 118:559-567.
18. Bevilaqua L.R., Kerr D.S., Medina J.H., Izquierdo I., Cammarota M. Inhibition of hippocampal Jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. European Journal of Neuroscience 2003, 17:897-902.
19. Costello D.A., Herron C.E. The role of c-Jun N-terminal kinase in the A beta-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology 2004, 46:655-662.
20. Li X.M., Li C.C., Yu S.S., Chen J.T., Sabapathy K., Ruan D.Y. JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. European Journal of Neuroscience 2007, 25:391-396.
21. Brecht S., Kirchhof R., Chromik A., Willesen M., Nicolaus T., Raivich G., et al. Specific pathophysiological functions of JNK isoforms in the brain. European Journal of Neuroscience 2005, 21:363-377.
22. Barry C.E., Nolan Y., Clarke R.M., Lynch A., Lynch M.A. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. Journal of Neurochemistry 2005, 93:221-231.
23. Curran B.P., Murray H.J., O'Connor J.J. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 2003, 118:347-357.
24. Eminel S., Roemer L., Waetzig V., Herdegen T. c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. Journal of Neurochemistry 2008, 104:957-969.
25. Zhao Y., Spigolon G., Bonny C., Culman J., Vercelli A., Herdegen T. The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria. Molecular and Cellular Neurosciences 2012, 49:300-310.
26. Zhao Y., Herdegen T. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria. Molecular and Cellular Neurosciences 2009, 41:186-195.
27. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science 1998, 282:2092-2095.
28. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997, 389:865-870.
29. Ennaceur A., Neave N., Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Experimental Brain Research 1997, 113:509-519.
30. Hryniewicz A., Bialuk I., Kaminski K.A., Winnicka M.M. Impairment of recognition memory in interleukin-6 knock-out mice. European Journal of Pharmacology 2007, 577:219-220.
31. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11:47-60.
32. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mechanisms of Development 1999, 89:115-124.
33. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Current Biology 1999, 9:116-125.
34. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology Biochemistry and Behavior 1996, 54:21-30.
35. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neuroscience and Biobehavioral Reviews 1997, 21:801-810.
36. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 2003, 463:3-33.
37. Sousa N., Almeida O.F., Wotjak C.T. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes, Brain and Behavior 2006, 5(Suppl. 2):5-24.
38. Kuan C.Y., Whitmarsh A.J., Yang D.D., Liao G., Schloemer A.J., Dong C., et al. A critical role of neural-specific JNK3 for ischemic apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15184-15189.
39. Chang L., Jones Y., Ellisman M.H., Goldstein L.S., Karin M. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Developmental Cell 2003, 4:521-533.
40. Bjorkblom B., Ostman N., Hongisto V., Komarovski V., Filen J.J., Nyman T.A., et al. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. Journal of Neuroscience 2005, 25:6350-6361.
41. Kornhauser J.M., Greenberg M.E. A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron 1997, 18:839-842.
42. Impey S., Obrietan K., Storm D.R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999, 23:11-14.
43. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Current Opinion in Neurobiology 2004, 14:311-317.
44. Westerlund N., Zdrojewska J., Padzik A., Komulainen E., Bjorkblom B., Rannikko E., et al. Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate. Nature Neuroscience 2011, 14:305-313.
45. Thomas G.M., Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience 2004, 5:173-183.
46. Walz R., Roesler R., Barros D.M., de Souza M.M., Rodrigues C., Sant'Anna M.K., et al. Effects of post-training infusions of a mitogen-activated protein kinase kinase inhibitor into the hippocampus or entorhinal cortex on short- and long-term retention of inhibitory avoidance. Behavioural Pharmacology 1999, 10:723-730.
47. Alonso M., Viola H., Izquierdo I., Medina J.H. Aversive experiences are associated with a rapid and transient activation of ERKs in the rat hippocampus. Neurobiology of Learning and Memory 2002, 77:119-124.
48. Ramin M., Azizi P., Motamedi F., Haghparast A., Khodagholi F. Inhibition of JNK phosphorylation reverses memory deficit induced by beta-amyloid (1-42) associated with decrease of apoptotic factors. Behavioural Brain Research 2011, 217:424-431.
49. Sherrin T., Blank T., Todorovic C. c-Jun N-terminal kinases in memory and synaptic plasticity. Reviews in the Neurosciences 2011, 22:403-410.
50. Berman D.E., Hazvi S., Rosenblum K., Seger R., Dudai Y. Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat. Journal of Neuroscience 1998, 18:10037-10044.
51. Vereker E., O'Donnell E., Lynch M.A. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. Journal of Neuroscience 2000, 20:6811-6819.
52. Galeotti N., Ghelardini C. Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation. International Journal of Neuropsychopharmacology 2012, 15:781-793.
53. Budziszewska B., Szymanska M., Leskiewicz M., Basta-Kaim A., Jaworska-Feil L., Kubera M., et al. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. Journal of Physiology and Pharmacology 2010, 61:207-215.
54. Sharma N., Deshmukh R., Bedi K.L. SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacology Biochemistry and Behavior 2010, 96:386-394.
55. Clarke M., Pentz R., Bobyn J., Hayley S. Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibition. PLoS ONE 2012, 7:e44073.
56. Tischmeyer W., Grimm R., Schicknick H., Brysch W., Schlingensiepen K.H. Sequence-specific impairment of learning by c-jun antisense oligonucleotides. Neuroreport 1994, 5:1501-1504.
57. Anokhin K.V., Mileusnic R., Shamakina I.Y., Rose S.P. Effects of early experience on c-fos gene expression in the chick forebrain. Brain Research 1991, 544:101-107.
58. Freeman F.M., Rose S.P. MK-801 blockade of Fos and Jun expression following passive avoidance training in the chick. European Journal of Neuroscience 1995, 7:563-569.
59. Freeman F.M., Rose S.P. Expression of Fos and Jun proteins following passive avoidance training in the day-old chick. Learning and Memory 1999, 6:389-397.
60. Chihab R., Ferry C., Koziel V., Monin P., Daval J.L. Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons. Brain Research. Molecular Brain Research 1998, 63:105-120.
61. Pozas E., Ballabriga J., Planas A.M., Ferrer I. Kainic acid-induced excitotoxicity is associated with a complex c-Fos and c-Jun response which does not preclude either cell death or survival. Journal of Neurobiology 1997, 33:232-246.
62. Kim Y.H., Choi S.S., Lee J.K., Won J.S., Choi M.R., Suh H.W. Possible roles of JNK pathway in the regulation of hippocampal proenkephalin and immediate early gene expression induced by kainic acid. Molecules and Cells 2001, 11:144-150.
63. Coffey E.T., Smiciene G., Hongisto V., Cao J., Brecht S., Herdegen T., et al. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. Journal of Neuroscience 2002, 22:4335-4345.
64. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Dérijard B., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO Journal 1996, 15:2760-2770.
65. Muller D., Nikonenko I., Jourdain P., Alberi S. LTP, memory and structural plasticity. Current Molecular Medicine 2002, 2:605-611.
66. Woolf N.J., Zinnerman M.D., Johnson G.V. Hippocampal microtubule-associated protein-2 alterations with contextual memory. Brain Research 1999, 821:241-249.
67. Diviani D., Scott J.D. AKAP signaling complexes at the cytoskeleton. Journal of Cell Science 2001, 114:1431-1437.
68. Abel T., Nguyen P.V., Barad M., Deuel T.A., Kandel E.R., Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 1997, 88:615-626.
69. Nguyen P.V., Woo N.H. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Progress in Neurobiology 2003, 71:401-437.
70. Bogoyevitch M.A., Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiology and Molecular Biology Reviews 2006, 70:1061-1095.
71. Sananbenesi F., Fischer A., Schrick C., Spiess J., Radulovic J. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1. Molecular and Cellular Neurosciences 2002, 21:463-476.
72. Strekalova T., Zorner B., Zacher C., Sadovska G., Herdegen T., Gass P. Memory retrieval after contextual fear conditioning induces c-Fos and JunB expression in CA1 hippocampus. Genes, Brain and Behavior 2003, 2:3-10.
73. Nisell M., Nomikos G.G., Chergui K., Grillner P., Svensson T.H. Chronic nicotine enhances basal and nicotine-induced Fos immunoreactivity preferentially in the medial prefrontal cortex of the rat. Neuropsychopharmacology 1997, 17:151-161.
74. Nuutinen S., Barik J., Jones I.W., Wonnacott S. Differential effects of acute and chronic nicotine on Elk-1 in rat hippocampus. Neuroreport 2007, 18:121-126.
75. Winchester C.L., Ohzeki H., Vouyiouklis D.A., Thompson R., Penninger J.M., Yamagami K., et al. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. Human Molecular Genetics 2012, 21:4910-4921.
76. Haeusgen W., Herdegen T., Waetzig V. MKK7gamma1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection. Cellular Signalling 2011, 23:1281-1290.
77. Haeusgen W., Herdegen T., Waetzig V. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7. European Journal of Cell Biology 2011, 90:536-544.
78. de Anda F.C., Rosario A.L., Durak O., Tran T., Graff J., Meletis K., et al. Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex. Nature Neuroscience 2012, 15:1022-1031.
79. Barnat M., Enslen H., Propst F., Davis R.J., Soares S., Nothias F. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. Journal of Neuroscience 2010, 30:7804-7816.
80. Sherrin T., Blank T., Hippel C., Rayner M., Davis R.J., Todorovic C. Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning. Journal of Neuroscience 2010, 30:13348-13361.
81. Pirianov G., Brywe K.G., Mallard C., Edwards A.D., Flavell R.A., Hagberg H., et al. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1022-1032.
82. Yamasaki T., Kawasaki H., Nishina H. Diverse roles of JNK and MKK pathways in the brain. Journal of Signal Transduction 2012, 2012:459265.
83. Ruff C.A., Staak N., Patodia S., Kaswich M., Rocha-Ferreira E., Da Costa C., et al. Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate. Journal of Neurochemistry 2012, 121:607-618.